Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hepatitis | D006505 | — | K75.9 | — | 1 | 4 | 2 | — | 7 |
Hepatitis a | D006506 | EFO_0007305 | B15 | — | 1 | 4 | 2 | — | 7 |
Hepatitis b | D006509 | — | — | 1 | 2 | 1 | 3 | — | 6 |
Chronic hepatitis b | D019694 | EFO_0004239 | B18.1 | 1 | 2 | 1 | 2 | — | 5 |
Carcinoma | D002277 | — | C80.0 | 1 | 2 | — | 1 | 1 | 4 |
Sepsis | D018805 | EFO_0001420 | A41.9 | — | — | 1 | 1 | 2 | 4 |
Toxemia | D014115 | — | — | — | — | 1 | 1 | 1 | 3 |
Hepatocellular carcinoma | D006528 | — | C22.0 | — | 1 | — | 1 | — | 2 |
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | — | 1 | — | 1 | — | 2 |
Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | — | — | 2 | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Colorectal neoplasms | D015179 | — | — | — | 2 | 1 | — | 1 | 4 |
Covid-19 | D000086382 | — | U07.1 | 1 | 2 | 1 | — | — | 4 |
Hepatitis c | D006526 | — | B19.2 | — | — | 3 | — | — | 3 |
Chronic hepatitis c | D019698 | EFO_0004220 | B18.2 | — | — | 3 | — | — | 3 |
Coronavirus infections | D018352 | EFO_0007224 | B34.2 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lung neoplasms | D008175 | — | C34.90 | 1 | 7 | — | — | 2 | 9 |
Non-small-cell lung carcinoma | D002289 | — | — | 1 | 5 | — | — | 2 | 7 |
Small cell lung carcinoma | D055752 | — | — | 1 | 3 | — | — | — | 3 |
Neoplasms | D009369 | — | C80 | 1 | 3 | — | — | — | 3 |
Adenocarcinoma | D000230 | — | — | — | 2 | — | — | — | 2 |
Radiotherapy | D011878 | — | — | — | 2 | — | — | — | 2 |
Hematologic neoplasms | D019337 | — | — | 1 | 2 | — | — | — | 2 |
Pneumonia | D011014 | EFO_0003106 | J18 | — | 1 | — | — | — | 1 |
Adenocarcinoma of lung | D000077192 | — | — | — | 1 | — | — | — | 1 |
Melanoma | D008545 | — | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hiv infections | D015658 | EFO_0000764 | B20 | 2 | — | — | — | — | 2 |
Infections | D007239 | EFO_0000544 | — | 1 | — | — | — | — | 1 |
Hiv seropositivity | D006679 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Aortic dissection | D000784 | — | I71.0 | — | — | — | — | 2 | 2 |
Liver failure | D017093 | — | K72.9 | — | — | — | — | 1 | 1 |
Hepatic insufficiency | D048550 | — | — | — | — | — | — | 1 | 1 |
Acute aortic syndrome | D000094683 | — | — | — | — | — | — | 1 | 1 |
Cardiopulmonary bypass | D002315 | — | — | — | — | — | — | 1 | 1 |
Heart diseases | D006331 | EFO_0003777 | I51.9 | — | — | — | — | 1 | 1 |
Rheumatic heart disease | D012214 | EFO_1001161 | I09.9 | — | — | — | — | 1 | 1 |
Immunotherapy | D007167 | — | — | — | — | — | — | 1 | 1 |
Rheumatic diseases | D012216 | — | M79.0 | — | — | — | — | 1 | 1 |
Squamous cell carcinoma | D002294 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Thymalfasin |
INN | thymalfasin |
Description | THYMALFASIN |
Classification | Protein |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(C)=O)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O |
PDB | — |
CAS-ID | 62304-98-7 |
RxCUI | — |
ChEMBL ID | CHEMBL2103979 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | W0B22ISQ1C (ChemIDplus, GSRS) |